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Selective portal vein embolization and ligation trigger different
regenerative responses in the rat liver
Abstract
Two strategies are clinically available to induce selective hypertrophy of the liver: portal vein
embolization (PVE) and portal vein ligation (PVL). The aim of this study was to compare the impact of
PVE and PVL on liver regeneration. Rats were subjected to 70% PVL, 70% PVE, 70% partial
hepatectomy (PH) (positive control), or sham operation (negative control). PVL and PVE of liver
segments were validated by portography and histology, demonstrating obstruction of the involved portal
branches. Liver weight and markers of regeneration were assessed at 24, 48, and 72 hours, and 7 days
after surgery (n = 5). Sinusoidal perfusion was examined by intravital microscopy. The weight of the
regenerating liver segments increased continuously in all groups, with the highest weight gain after PH,
which also disclosed the strongest proliferative activity. In Ki-67 and PCNA stainings, hepatocyte
proliferation after PVL was more pronounced than after PVE (P = 0.01). Volumetric blood flow and
functional sinusoidal density were lower after PVE than after PVL (P = 0.006, P = 0.02, respectively).
The accumulation of Kupffer cells 24 hours after the intervention was highest after PH. Transcript levels
of cytokines (interleukin-1beta, tumor necrosis factor-alpha, interleukin-6) peaked at 24 hours and were
highest after PH. The embolized part of the liver after PVE showed prominent foreign body reaction in
the portal triad with accumulation of macrophages. Conclusion: PVL is superior to PVE in inducing a
regenerative response of the remnant liver. The impairment of liver regeneration after PVE may be a
consequence of macrophage trapping in the occluded segment due to a foreign body reaction. Lower
blood flow and lower accumulation of macrophages, particularly Kupffer cells, in the regenerating part
of the liver likewise causes impaired liver regeneration after PVE.
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Two strategies are clinically available to induce selective hypertrophy of the liver; 
portal vein embolization (PVE) and portal vein ligation (PVL). The aim of this study 
was to compare the impact of PVE and PVL on liver regeneration. Rats were 
subjected to 70% PVL, 70% PVE, or 70% partial hepatectomy (positive control) or 
sham operation (negative control). PVL and PVE of liver segments were validated 
by portography and histology demonstrating obstruction of the involved portal 
branches. Liver weight and markers of regeneration were assessed at 24hr, 48hr, 
72hr, and 7 days after surgery (n=5). Sinusoidal perfusion was examined by 
intravital microscopy. The weight of the regenerating liver segments increased 
continuously in all groups with the highest weight gain after PH, which also 
disclosed the strongest proliferative activity. In Ki67 and PCNA stainings, 
hepatocyte proliferation after PVL was more pronounced than PVE (p=0.01). 
Volumetric blood flow and functional sinusoidal density were lower after PVE vs. 
PVL (p=0.006, p=0.02 respectively). The accumulation of Kupffer cells 24hr after 
the intervention was highest after PH followed by PVL and PVE. Transcript levels 
of cytokines (Il-1β, TNF-α, IL-6) peaked at 24hr, and were highest after PH. The 
embolized part of the liver after PVE showed prominent foreign body reaction in 
portal triad with dramatic accumulation of macrophages. Conclusion: PVL is 
superior to PVE in inducing a regenerative response of the remnant liver. The 
impairment of liver regeneration after PVE may be a consequence of macrophage 
trapping in the occluded segment due to a foreign body reaction. Lower blood flow, 
and lower accumulation of macrophages, particularly Kupffer cells, in the 






Liver resection is the only chance of cure in many patients with primary or 
secondary liver tumors (1). One limiting factor for success is the size and function 
of the remnant liver left after surgery (1-2). Owing to the unique and versatile 
ability of the liver to regenerate, a number of strategies have been developed to 
increase the volume of a potential future remnant liver. Already a century ago, 
experiments in rabbits showed that selective occlusion of a large branch of the 
portal vein causes atrophy of the ipsilateral lobe and hypertrophy of the contra 
lateral liver lobe (3). In the late eighties, Makuuchi et al.(4) first applied selective 
occlusion of a branch of the portal vein to induce hypertrophy of the future remnant 
liver in patients requiring major hepatectomy. This strategy is currently used in 
many centers worldwide to extend the limit of liver resection (1).  
 
Selective occlusion of tributaries of the portal vein can be achieved in patients 
by portal vein embolization (PVE), usually performed percutaneously with 
microspheres, cyanoacrylate, fibrin glue, ethanol, or portal vein ligation (PVL) 
performed during open or laparocopic surgery. While many clinicians believe that 
PVE is superior to PVL (5), convincing data is lacking. One retrospective study in 
patients undergoing major hepatectomy suggested better regenerative ability of 
the liver after PVE rather than PVL (5). Another recent prospective study in 
patients undergoing preoperative PVE prior to a hemihepatectomy failed to show 
any clinical advantages (6). Subsequent study from the same group suggested 
better regenerative ability following PVL compared to PVE (7). These 
controversies are further enhanced by the lack of validated animal models of PVE. 
Likewise the regenerative response differs significantly considering that PVL 
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results in the complete absence of flow proximally to a well define territory of the 
liver, while PVE causes impairment in flow by foreign bodies located peripherally, 
usually in the pre-sinusoidal veins. 
 
Therefore, we compared the impact of portal PVE and PVL on liver 
regeneration of the contra-lateral segments and atrophy of the ipsilateral 
segments. We first validated comparable models of PVL and PVE, and used an 
established model of partial hepatectomy (PH) as a positive control. We also 
explored putative mechanisms of regeneration, which may explain the different 
response in inducing hepatocyte proliferation. 
 
Material and Methods 
Animals 
Experiments were performed on male Wistar rats weighting 250-280g (Harlan, The 
Netherlands). Animals were kept in the animal facility of the University Hospital 
Zurich with access to standardized chow and water ad libitum. All procedures were 
approved by the Veterinary Office of the Canton Zurich and were performed 
between 8 and 12 am., in compliance with institutional animal care guidelines for 
experimental animals from the Zurich Veterinary Institution. Group size was n=5 
per each study group unless otherwise indicated. 
 
Operative procedure 
A model of 70% partial hepatectomy, a selective portal vein ligation and selective 
portal vein embolization or sham operation was used in all groups of experiments. 
Rats were anesthetized with inhalation of isoflurane/O2 (Halocarbon Laboratories, 
River Edge, NJ) and constant gas mixture was maintained with a vaporizer system 
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(Provet, Basel, Switzerland). After a midline laparotomy the liver was freed from its 
ligaments. Sham operated animals were closed again by a double running suture. 
Buprenorphin (0.1mg/kg body weight) was applied intraperitoneally during 




A model of 70% partial hepatectomy was performed according to a modification (8, 
9) of the standard method described by Higgins and Anderson in 1931(10). Briefly, 
after a midline laparotomy, the liver was freed from its ligaments. Subsequently, 
we performed the ligation of the whole left lateral lobe, right hepatic lobe (divided 
by a horizontal fissire into superior and inferior right lobe) and the caudate lobe 
(divided in anterior and posterior caudate lobe) with 6-0 silk followed by resection 
of ligated liver lobes.  
 
Portal vein ligation 
Selective portal vein ligation was performed on quadrant lobe, left lobe, upper right 
and lower right lobe. After carreful dissection of the hepatic artery, the 
corresponding portal veins of the liver were ligated with 7-0 Fumalen. Portography 
was performed before portal vein ligation to visualize the liver anatomy. 
Portography was repeated after the selective portal vein ligation to demonstrate 
portal occlusion of appropriate liver segments. 
 
Portal vein embolization 
For portal vein embolisation the cental portal vein was punctured with a 20-gauge 
needle (BD, Insyte™). The needle was connected with a three-way stopcock and 
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a 1ml syringe filled with 0.9% physiological saline solution to prevent air bubble 
intrusion. The syringe and the catheter was fixed with 6-0 silk. Subsequently, we 
performed angiography of the liver by injecting 1ml of Telebrix (1:4 diluted with 
0.9% NaCl: 0.25ml Telebrix +0.75ml 0.9% NaCl) into the portal vein. As a next 
step, 30 % of the portal vein was occluded with the vascular clamp (Aesculap®, 
Ref FE710K). One ml of Embosphere® (Ref. S220GH) diluted 1:10 in 0.9%NaCl 
was injected. Embosphere® is an acrylic co-polymer trisacryl, cross-linked with 
gelatin that allows a precise match of sphere and vessel lumen diameters. This 
material is non aggregating and is able to increase its volume due to its 
hydrophylic surface. After the succesful embolisation the catheter is flushed with 
0.2ml, 0.9% physiological saline solution. Portography was repeated to 
demonstrate occlusion of the appropriate liver segments. The hepatic artery 
remained patent in both PVL and PVE group. At the end of surgery, the abdomen 
was closed by 4-0 Vicryl® double layer running suture.  
 
In vivo fluorescence microscopy and analysis of microcirculation 
Intravital microscopy was performed as described previously(11). Functional 
sinusoidal density (FSD) was defined as the total length of all perfused sinusoids 
per observation area (cm/cm2) (12). The red blood cell (RBC) velocity and 
sinusoidal diameter were measured in 10 sinusoids in the midzonal region. 
Volumetric blood flow in each sinusoid was calculated from the velocity of RBCs 
and the cross sectional surface area (π X r2) according to the following equation 
(13): VBF=RBC velocity x cross sectional surface area. FSD and sinusoidal 
diameter were assessed by a computer-assisted image analysis software system 
(CapImage; Zeintl Software, Heidelberg, Germany). 
 
 8
Analysis of portal flow 
Portal flow was measured in main trunk of portal vein before their division into the 
liver (Doppler Transonic Systems Inc., Altron; Germany). 
 
Liver weight 
After partial hepatectomy and harvesting (PVL and PVE group) the weight of the 
regenerating, the resected and the atrophied lobes was measured using a 
laboratory micro scale (Sartorius, Germany) 
 
AST and ALT levels 
Blood samples obtained from the inferior vena cava at different time points of liver 
regeneration were immediately centrifuged at 2000g for 6 minutes. Aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT) levels were 




Liver tissues were immersion fixed in 4% formaldehyde, embedded, sectioned and 
stained with hematoxylin-eosin using standard histological techniques. In addition, 
liver sections were immunostained for proliferating cell nuclear antigen (PCNA) 
(FITC-labeled monoclonal mouse clone PC10, Abcam) and Ki-67 (monoclonal 
rabbit clone SP6; NeoMarkers) using the Ventana Discovery automated staining 
system with iView DAB kit (Ventana, Tucson, AZ). Sections were also stained with 
monoclonal ED1 antibody (CD68 Serotec/Carnon, Germany) and α-SMA 
(Biogenex, MU128-CU), using a streptavidin-biotin immunoperoxidase method. 
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All immunostains were counterstained with hematoxylin. Neutrophilic granulocytes 
were stained using the AS-D chloroacetate esterase (CAE) technique. The 
number of Ki-67 and PCNA positive hepatocytes and ED1+ 
monocytes/macrophages and neutrophilic granulocytes was determined in 10 
random high power fields (magnification 400x). Necrotic areas after PVE or PVL 
were quantified in 10 visual fields (magnification 100x) using a Carl Zeiss 
AxioVision 4 LE programme (Carl Zeiss, Jena, Germany). 
All histological analyses were performed in a blinded fashion with respect to the 
experimental group. 
 
Quantitative Real-Time PCR 
Total RNA was extracted from 50mg of liver tissue using TRIzol reagent 
(Invitrogen, Paisley, UK). Five micrograms of RNA were reverse-transcribed using 
the Thermoscript RT-PCR kit (Invitrogen, Basel, Switzerland) yielding the 
complementary DNA template. Quantitative real-time PCR amplification and data 
analysis were performed using an ABI Prism 7000 Sequence Detector system. 
TaqMan gene expression assays (PE Applied Biosystems, Rotkreuz, Switzerland) 
for IL-1β (Rn00580432_m1), IL-6 (Rn00561420_m1) and TNF-α 
(Rn99999017_m1) were used to quantify mRNA expression of the respective 
genes. Messenger RNA expression levels for each sample were normalized to 




All data are expressed as means ± SD. After proving the assumption of normality 
and homogeneity of variance across groups, differences between the groups were 
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assessed by one-way ANOVA or two-way ANOVA (Bonferroni posttest), using an 
appropriate post-hoc comparison test, including Newman-Keuls probabilities to 
compensate for multiple comparisons. Ordinal variables were compared with the 
Mann-Whitney test. A significant difference was assumed when P was smaller 
than 0.05. Statistics were performed using the software package GraphPad 4.0 
and SPSS 12.0.1.  
 
Results 
Are the models of PVE, PVL and hepatectomy comparable?  
First, we performed experiments to secure the effectiveness of the different 
strategies used to trigger a proliferative response. The model of partial 
hepatectomy is well established and consists of a 70% removal of the liver. The 
weight of the resected part of the liver compared to the total liver weight was 7.4 ± 
0.7 g to 10.9 ± 0.5 g (n=5) (68%). Both PVL and PVE were performed in the same 
liver segments that were resected for partial hepatectomy. The model of PVL and 
PVE consisted of the ligation or embolization, of the same branch of the portal vein 
as used in the model of partial hepatectomy. We performed a portography before 
PVL and PVE to document the liver vascular anatomy and after to see the 
occluded territory of the portal system and the perfusion of the remnant liver 
(Figure 1). Comparable territories of the liver were excluded from perfusion using 
either PVE or PVL and we concluded that valid comparisons can be drawn from 
these models.  
 
 
Do PVL or PVE cause liver injury? 
Formatiert: Nicht unterstrichen
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Next, we tested whether PVE or PVL caused liver injury. We measured serum 
transaminase (AST and ALT) levels as established markers of hepatocyte injury 
and performed histological examination of the occluded part of the liver, 
respectively. Both PVE and PVL caused a comparable increase in AST and ALT 
levels, which was lower than after partial hepatectomy (Figure 2).  
 
Histological analysis after PVL or PVE revealed areas of necrosis in the 
occluded part of the liver, which were significantly larger after PVL than PVE at 24 
hrs after surgery (44.4 ± 9.2 % vs. 12.6 ± 8.8 %, p<0.001) (Figure 3). When tissue 
was analyzed 7 days after PVL and PVE (Fig. 3) areas of necrosis appeared 
resolved. Consistent with the observation of centrolobular necrosis after PVL we 
found also centrolobular accumulation of myofibroblasts (α-SMA staining). In 
contrast, myofibroblast accumulation was found around the occluded portal veins 
after PVE. The presence of fibrosis was tested by Sirius red staining of collagen, 
which showed no substantial fibrosis in the occluded liver segments after PVL and 
PVE 
 
What is the impact of partial hepatectomy, PVE and PVL on liver 
regeneration? 
To determine the effects of hepatectomy, PVE and PVL on contralateral liver 
regeneration we measured the liver weight and markers of hepatocyte 
proliferation. As shown in Figure 4, partial hepatectomy induced the highest 
response with an increase of the remnant liver from baseline of 3.5g (± 0.3) to 7.1g 
(± 0.9) by postoperative day 7. PVL exhibited a delayed growth but reached a 
similar weight 7 days after ligation. In contrast, PVE induce a blunted regenerative 







To further characterize the regenerative response we assessed Ki67 and 
PCNA staining, two nuclear antigens associated with proliferation at all time points 
after surgery (Figure 5). As expected, both markers were expressed in numerous 
hepatocytes in the partial hepatectomy group. PVL and PVE exhibited reduced 
proliferative activities at 48 hrs, which was consistent with the liver weights. Both 
Ki-67 and PCNA labeling indices were lower in the PVE group (Fig. 5).  
 
What factor might explain the different regenerative response?  
We next focused on possible mechanisms explaining the different 
regenerative response. While the observation of the highest response associated 
with partial hepatectomy was expected, the superior response of PVL over PVE 
was not. Our first line of investigation focused on the release of established 
mediators of liver regeneration including TNF-α, interleukin IL-1β and IL-6. These 
cytokines are released from non-parenchymal liver cells, i.e. Kupffer cells, after 
hepatectomy (14) and promote hepatocyte to DNA synthesis and hepatocyte 
proliferation. Evidence has been provided that activated Kupffer cells produce 
TNFα, which in turn, up-regulates the expression of IL-6. TNF-α and IL-6 activate 
neighboring hepatocytes (15) to move from the G0 phase to the proliferative cycle 
(15-19). These growth cytokines were highly up-regulated in the regenerating lobe 
24 hr after partial hepatectomy compared to sham operated animals (Figure 6). 
We observed a significant increase after PVL, although less than after partial 
hepatectomy. In contrast, we failed to demonstrate a significant cytokine response 
after PVE. This data is consistent with the regenerative response observed in the 





Considering that the putative primary sites of cytokine production after 
hepatectomy are the Kupffer cells, we next determined the number of Kupffer cells 
in the regenerating lobe using immunohistochemistry. In sham control animals, 23 
± 6.7 positive cells/HPF were detected throughout the liver. Partial hepatectomy 
caused a 6-fold increase in the density of Kupffer cells 24 hr after surgery (156 ± 
37.7 positive cells/HPF) (Figure 7). PVL resulted in a slightly lower number of 
ED1+ positive cells in the regenerating lobe (120 ± 18.8 positive cells/HPF), while 
PVE induced a significant but limited (3x increase) response with 57 ± 3.8 positive 
cells/HPF. This data is in line with the previously observed regenerative response 
and growth cytokine release. 
 
Do PVE and PVL result in similar degree of changes in portal and 
sinusoidal flow? 
One explanation for the differences in the regenerative response between 
PVL and PVE might be related to a difference in the ability to block portal flow in 
the ipsilateral lobe and induce higher portal pressure in the contra-lateral lobe. We 
assessed sinusoidal perfusion 24 hr after surgery using intravital microscopy. 
Functional sinusoidal density, volumetric blood flow and erythrocyte velocity (VRBC) 
were lower in regenerating livers after PVE in comparison with PVL and PH 
(Figure 8, Table 1). To assess whether these changes correlate with portal flow in 
the PVL model, we measured portal flow using a Doppler transonic system 24 hr 
after selective portal vein occlusion. There were no statistically significant 
differences in the main portal flow between PVL (18.0 ± 0.5) and PVE (15.5 ± 3.3) 
while in the hepatectomized group the flow was higher (22.7 ± 3.0 ml/min). This 







related to “intra parenchymal” mechanisms, rather than different hemodynamic 
effects on the portal flow after partial hepatectomy, PVE and PVL. 
 
May changes in the atrophied liver lobe influence the regenerative 
response of the contra-lateral lobe? 
The striking difference between PVE and PVL in the regenerative response of 
the contra lateral liver lobes led us to investigate changes in ipsilateral lobes. Both 
PVE and PVL lead to a comparable atrophy of the ispilateral liver segments (Figure 
9). Next, we looked at changes in H-E stained biopsies of the atrophied lobe.  
 
Histological assessment of the PVE group demonstrated the presence of 
microspheres in small presinusoidal branches of the portal vein, as sequels of the 
embolization (Figure 10). Another striking finding was the presence of massive 
inflammatory reaction surrounding the microspheres. To further identify the 
infiltrating cell type, we performed specific staining for neutrophilic granulocytes 
and macrophages. As shown in figure 10, the majority of infiltrating cells were 
macrophages, with a very modest infiltration by neutrophilic granulocytes. 
 
Discussion 
This study was designed to shed some new light on the ability of two widely 
used clinical strategies of selective portal vein occlusion to induce a regenerative 
response on the contra lateral liver segments. After establishing reliable models of 
PVE and PVL in the rat, we found a significantly enhanced regenerative response 
after PVL, when compared to PVE. These unexpected findings seem related to a 
“foreign body reaction” with massive trapping of macrophages in the occluded part 





release of growth cytokines in the contra lateral (regenerative) segments. The 
additional impaired microcirculation observed after PVE in the regenerating liver 
appear to be rather a consequence of “intra-parenchymal” mechanisms, rather 
than changes in hemodynamics in the portal vein system. 
 
A critical part of such studies is the establishment of reliable and relevant 
models. In the human situation, it is necessary to occlude more than 50% of the 
portal vein flow to induce a sustained regenerative response on the contra lateral 
side. We chose in both models of PVE and PVL a 70% occlusion of the portal 
supply to the liver in order to compare the results with the well established model 
of 70% hepatectomy. The use of portography enabled us to convincingly identify 
the obstructed sectors of the portal vein. We used microspheres to cause distal 
PVE, a common modality used in patients worldwide. Other embolitic materials are 
also used occasionally for PVE such as fibrin glue, cyanoacrylate and ethiodized 
oil, gelatine and absolute alcohol (20). As the regenerative response was impaired 
due to the massive foreign body reaction in the liver, it is possible that different 
responses may be observed with different embolizing materials. 
 
The mechanism of regeneration identified in this study is novel, and may have 
significant implications for the future. The data converge to a primarily massive 
and diffuse foreign body reaction around the microspheres after PVE. Rapidly, 
macrophages accumulate in the occluded part of the liver, and may thereby not be 
available on the contra-lateral regenerating liver, blunting the initial proliferative 
response. The decreased amount of growth cytokines (TNF-α, IL-6 and IL-1β) is 
consistent with this observation. Another explanation could have been related to 
changes in the main portal flow influencing the regenerative response. While we 
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failed to show significant differences in the main portal flow among PVE, PVL, we 
did observe impaired microcirculation in the regenerating liver in the PVE group, 
but not in the PVL group. This data suggests that this alteration in the 
microcirculation is related to intraparenchymal mechanism, possibly including the 
release of soluble factors from Kupffer cells. 
 
The success of PVL was somewhat unexpected, and may provide further 
incentive to use this strategy in patients. Interestingly, a recent study (7) (Lesurtel 
is not the 1st author) suggested more efficient regeneration with selective PVL, 
compared to PVE. This study was however retrospective, and in a relatively low 
number of patients, and therefore caution is still required in recommending this 
modality in the clinic. Nevertheless, the results of our study provide strong 
evidence for the efficacy of PVL in inducing contra lateral hypertrophy of the liver. 
Accumulation of macrophages, the presence of growth factors and markers of 
regeneration were all significantly documented in the contra lateral segments. The 
values were close to the positive control of 70% partial hepatectomy.  
 
The results may also have implications for patients with liver tumors, who 
have a high tumor load and insufficient normal liver to tolerate a major liver 
resection. We recently showed that occlusion by PVL did not result in enhanced 
tumor growth on the contra lateral side (21). The impact of PVE and PVL on tumor 
growth will need to be studied with caution to optimally use these strategies in 
patients. In these patients portal occlusion is used prior to liver resection after 




In conclusion, we demonstrated in a rat model that selective induction of liver 
hypertrophy is highly dependent on the type of intervention. The superiority of PVL 
may be related to a full regenerative response including accumulation of 
macrophages and the release of growth cytokines. Strategies to prevent the 
massive foreign body reaction associated with PVE of microspheres may permit to 
get improved regeneration through this modality, which is easily applicable in 
patients through a percutaneous approach. PVL requires surgery using either a 
laparoscopic or open approach. This study opens the door for a number of 
experimental and clinical studies, for example in using different materials for PVE, 
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Figure 1: The rat liver before and after PVL and PVE.  
(A) Schematic anatomy of the rat liver lobes and portal vein (left) and a 
representative portography of the liver (right). Rat liver lobes: median lobe (ML), 
the left lateral lobe (LLL), the right lobe – divided in superior right lobe (SRL) and 
inferior right lobe (IRL), and caudate lobe – formed by the caudate process (CP) 
and Spiegel lobe with anterior (AC) and posterior (PC) portion.  
(B) Schematic presentation of PVL and portography after PVL. 
(C) Schematic presentation of PVE and portography after PVE.  
 
Figure 2: Quantification of hepatocellular injury after different surgical 
interventions. AST (A) and ALT (B) release in all time points. Partial hepatectomy 
(■), portal vein ligation (▲), portal vein embolization (▼). Histological analysis of 
the occluded liver lobes after PVL and PVE at 24 hr, 48 hr, 72 hr and 7 days after 
the intervention (C). 
There was a significant difference in AST release between PH and PVL at 24 hr 
after surgery (p<0.001) and between PH and PVE at 24 hrs and 48 hrs (p<0.001 
and p<0.05, respectively). The ALT release show a significant difference between 
PH and PVE at 24 hrs and 48 hrs (p<0.01 and p<0.05, respectively). 
Values are means ± SD. Two-way ANOVA indicated that the curves were 
significantly different for AST (p=0.0005) and for ALT (p=0.0056) using the 
Bonferroni post test. 
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Figure 3: Perivascular necrosis in liver lobes after portal vein ligation (A) and 
portal vein embolisation (B) at 24 hr time point. Morphometric analysis of the 
necrotic areas in all time points (C) show a significant difference at 24 hr 
(p<0.001). Values are means ± SD. Two-way ANOVA indicated that the curves 
were significantly different for area of necrosis (p=0.0002) with the Bonferroni post 
test. 
Analysis of the atrophic tissue 7 days after PVL (Fig. 3 D) and PVE (Fig. 3 E) for 
myofibroblasts (α-SMA staining). Sirius Red staining of the same tissue 
demonstrating no substantial fibrosis in PVL group (Fig. 3 F) by comparison to 
PVE (Fig. 3 G). 
 
Figure 4: Increase of liver weight of regenerating lobes after PH, PVL, PVE.  
Liver weight after various surgical procedures are presented at four different time 
points. Partial hepatectomy (■), portal vein ligation (▲), portal vein embolization 
(▼). The increase of liver weight at 72 hrs and at 7 days in the PVE group was 
significantly different to the PH group (p<0.01 and p<0.05, respectively). 
Values are means ± SD. Two-way ANOVA indicated that the curves were 
significantly different when comparing liver weights (p=0.002) using the Bonferroni 
post test. 
 
Figure 5: Regeneration of remnant livers after different surgical interventions. 
Livers (n=5 per group) were analyzed for Ki-67 (A) and PCNA (B) positive 
hepatocytes after partial hepatectomy (■), portal vein ligation (▲), portal vein 





per visual field is presented. The increase of Ki-67 positive cells show significant 
differences: PH vs. PVL (p<0.01), PH vs. PVE (p<0.001) and PVL vs. PVE 
(p<0.01) at 48 hrs after surgery. Values are means ± SD. Two-way ANOVA 
indicated that the curves were significantly different for increase of Ki-67 positive 
cells after different interventions (p=0.015) using a Bonferroni post test. PCNA also 
showed significant differences: PH vs. PVL (p<0.05), PH vs. PVE (p<0.001) and 
PVL vs. PVE (p<0.05) at 48 hrs after surgery. Values are means ± SD. Two-way 
ANOVA indicated that the curves were significantly different for increase PCNA 
positive cells after different interventions (p=0.036) using a Bonferroni post test. 
 
Figure 6: Effect of different surgical interventions on expression of inflammatory 
mediators in regenerating liver tissue at 24 hours after PH, PVL and PVE.  
mRNA levels coding for IL-6, TNF-α and IL-1β were determined by RT-PCR and 
given as fold induction relative to sham operated livers. Statistically significant 
differences are indicated by bars (means ± SD) and P-values (Mann-Whitney test 
with two-tailed P value) 
 
Figure 7: Kupffer cell/macrophage accumulation in regenerating liver lobes.  
Immunohistochemistry of liver sections stained with ED1 (CD68) as a marker for 
monocytes and macrophages at 24h (n=5 per group). Positive cells were counted 
and expressed as mean number of macrophages per high-power field (x400). 
Values are means ± SD. Mann-Whitney test with two-tailed P value 
 






Quantitative analysis of functional sinusoidal density (A), volumetric blood flow (B) 
and RBC velocity (C) in regenerating liver lobes at 24h after different surgical 
interventions. Representative intravital fluorescence microscopy images displaying 
the functional sinusoidal density in control liver and, after PH, PVL and PVE (D). 
Statistical significance indicated by bars (means ± SD) and the respective Mann-
Whitney test with two-tailed P value. 
 
Figure 9: Influence of PVL and PVE on liver atrophy. Weight of the ipsilateral 
lobes after various surgical procedures are presented at four different time points. 
PVL- portal vein ligation (▲), PVE- portal vein embolization (▼). Values are 
means ± SD. (p=0.1260, one-way ANOVA). 
 
Figure 10: Effect of injection of embolizing microspheres on granulocyte infiltration 
and accumulation of Kupffer cells in rat livers 24 hours after PVE in the atrophied 
lobe. 
Embolized part of livers were processed for H-E staining (A). Granulocytes were 
stained using alpha-naphthyl chloroacetate estase staining – see arrows (B). 
Monocytes and macrophages including Kupffer cells were detected by 
immunohistochemistry using ED1/CD68 antibody (C). 
 
Table 1: Values of functional sinusoidal density, volumetric blood flow and RBC 
velocity in regenerating liver lobes using in vivo fluorescence microscopy, at 24h 
after sham laparotomy, PH, PVL and PVE. 
 control PH PVL PVE 
Functional sinusoidal density (cm/cm2)     
Formatiert: Nicht unterstrichen
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Mean 631.4 583.6 580.2 518.0 
Std. Deviation 79.94 105.5 110.3 56.71 
95% CI of mean 601.6 544.2 539.1 496.9 
Volumetric blood flow (pl/s)     
Mean 11.58 12.28 12.16 9.627 
Std. Deviation 2.576 2.835 2.497 2.860 
95% CI of mean 10.62 11.22 11.23 8.559 
RBC velocity (μm/s)     
Mean 216.6 236.7 229.2 169.0 
Std. Deviation 13.97 29.00 22.94 32.61 
95% CI of mean 211.4 225.9 220.6 156.9 
 
 
